Literature DB >> 11226754

Microglial response to the neurotoxicity of 6-hydroxydopamine in neonatal rat cerebellum.

I Podkletnova1, J D Rothstein, P Helén, H Alho.   

Abstract

Depletion of noradrenaline in newborn rats by 6-hydroxydopamine (6-OHDA) affects the postnatal development and reduces the granular cell area in the neocerebellum (lobules V-VII). During the first postnatal month, Bergmann glial fibers guide the migration of immature granule cells to the internal granule cell layer. Microglia and Bergmann glia may play an important role in this process, but the exact mechanism behind this phenomenon is not known. We studied the effect of systemic administration of 6-OHDA on the expression and localization on microglia and Bergmann glia in the neonatal cerebellum by immunohistochemistry. In the neocerebellum, 6-OHDA treatment caused a significant increase in the number of activated microglia. The increase was observed mainly in the granule cell layer and the cerebellar medulla. Bergmann glial cells in treated brains were abnormally located, did not form intimate associations with Purkinje cells, and the glial fibers were structurally different. Our findings indicate that a noradrenergic influence may be necessary for the normal maturation and migration of granule cells, and abnormal migration may be the result of Bergmann glia destruction and the activation of microglia. Activated microglia in the granule cell layer may be used as a marker for an injured cerebellar area.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11226754     DOI: 10.1016/s0736-5748(00)00069-1

Source DB:  PubMed          Journal:  Int J Dev Neurosci        ISSN: 0736-5748            Impact factor:   2.457


  5 in total

1.  Alterations in the development of rat cerebellum and impaired behavior of juvenile rats after neonatal 6-OHDA treatment.

Authors:  I Djatchkova-Podkletnova; H Alho
Journal:  Neurochem Res       Date:  2005-12       Impact factor: 3.996

Review 2.  Dopamine transporters in the cerebellum of mutant mice.

Authors:  Panagiotis Giompres; Foteini Delis
Journal:  Cerebellum       Date:  2005       Impact factor: 3.847

3.  Antioxidant and Anti-Apoptotic Activity of Octadecaneuropeptide Against 6-OHDA Toxicity in Cultured Rat Astrocytes.

Authors:  Hadhemi Kaddour; Yosra Hamdi; Fatma Amri; Seyma Bahdoudi; Ibtissem Bouannee; Jérôme Leprince; Sami Zekri; Hubert Vaudry; Marie-Christine Tonon; David Vaudry; Mohamed Amri; Sana Mezghani; Olfa Masmoudi-Kouki
Journal:  J Mol Neurosci       Date:  2018-10-20       Impact factor: 3.444

Review 4.  Cerebellum in levodopa-induced dyskinesias: the unusual suspect in the motor network.

Authors:  Asha Kishore; Traian Popa
Journal:  Front Neurol       Date:  2014-08-18       Impact factor: 4.003

Review 5.  Cytoprotective and Neurotrophic Effects of Octadecaneuropeptide (ODN) in in vitro and in vivo Models of Neurodegenerative Diseases.

Authors:  Olfa Masmoudi-Kouki; Amira Namsi; Yosra Hamdi; Seyma Bahdoudi; Ikram Ghouili; Julien Chuquet; Jérôme Leprince; Benjamin Lefranc; Taoufik Ghrairi; Marie-Christine Tonon; Gérard Lizard; David Vaudry
Journal:  Front Endocrinol (Lausanne)       Date:  2020-11-04       Impact factor: 5.555

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.